Answers are grounded in this paper and cite their sources.
: based on the univariate Cox regression model, six clinical characteristics showed a statistically significant effect on overall survival: sex, lymph node involvement, use of chemotherapy in the first line of treatment, low neutrophil count and neutrophil/lymphocyte ratio in the peripheral blood sample, which formed the basis for the formation of prognostic groups. This retrospective analysis of the first-line efficacy of patients with unresectable or metastatic NSCLC showed that the poor prognosis group may have a lower OS benefit with the addition of immunotherapy (9.4 months vs 9.8 months, p=0.256), compared with group with a favorable prognosis (19.9 months vs 23.6 months, p=0.045). Conclusions: definition of prognostic groups can be one of significant factors that could influence necessity of checkpoint inhibitors therapy. Researching of different therapy options efficacy in prognostic groups can lead to more precision usage of novel drugs.
No takes yet. Share an insight, caveat, or question.
Krasavina et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: